The following is a summary of "Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...

New injectable hydrogel regulates immune cell metabolism, reducing inflammation and slowing rheumatoid arthritis progression.

Generation Bio Co. is developing siRNA therapeutics for T cell-driven autoimmune diseases using its T cell-selective lipid nanoparticle technology. This innovative delivery system aims to ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 ...

Itoophiyaa biyya seenaa waggaa hedduu qabdu, ammoo dimokiraasiif daa'imaa...... Bara 1974 warraaqsi barattoota yuunvarsiitii ...

Given the growing antibiotic resistance crisis, novel ways to target bacterial infections are becoming increasingly important. One potential strategy is to manipulate bacterial genes at the ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

The Next Generation doesn't truly hit its stride until season 3, but the show's second season delivers some genuinely ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeutics, Inc ...

From natural stone countertops to well-made furniture, here are the timeless decorating decisions you'll never regret, ...